Ceftiofur Sodium ntụ ntụ maka igba ogwu
.png)
.png)
.png)
.png)
Pharmacological omume
PharmacodynamicsCeftiofur bụ ọgwụ nje β-lactam nwere mmetụta nje na-egbu egbu ma dị irè megide nje bacteria gram-positive na gram-adịghị mma (gụnyere β-lactamase na-emepụta nje bacteria).Usoro nje ya bụ igbochi njikọ nke mgbidi cell nje na-akpata ọnwụ nje.Ụfọdụ Pseudomonas aeruginosa na enterococci na-eguzogide ọgwụ.Ọrụ antibacterial nke ngwaahịa a siri ike karịa nke ampicillin, yana ọrụ ya megide streptococci siri ike karịa nke fluoroquinolones.
PharmacokineticsIntramuscular na subcutaneous injections nke ceftiofur na-etinye ngwa ngwa ma kesaa ebe niile, mana enweghị ike ịbanye na mgbochi ụbụrụ ọbara.Ntinye uche nke ọgwụ n'ime ọbara na anụ ahụ dị elu, a na-edobekwa itinye uche ọgwụ ọbara dị irè ruo ogologo oge.Metabolite na-arụ ọrụ desfuroylceftiofur (Desfuroylceftiofur) nwere ike imepụta n'ime ahụ, wee metabolite n'ime ngwaahịa na-adịghị arụ ọrụ ka a ga-ewepụ ya na mmamịrị na nsị.
Ọrụ na ojiji
β-Lactam ọgwụ nje.A na-ejikarị agwọ ọrịa nje nke anụ ụlọ na anụ ọkụkọ.Dị ka ehi, ezì nje nje iku ume tract ọrịa na ọkụkọ Escherichia coli, Salmonella ọrịa na na.
Ojiji na usoro onunu ogwu
Ceftiofur gbakọrọ.Intramuscular injection: otu dose, 3 ~ 5mg kwa 1kg arọ ahụ maka ezì;otu ugboro n'ụbọchị, maka ụbọchị atọ n'usoro.Ngwunye subcutaneous: 0.1 mg kwa nnụnụ maka ọkụkọ dị otu ụbọchị
Mmeghachi omume ọjọọ
(1) Ọ nwere ike ịkpata ọgba aghara flora eriri afọ ma ọ bụ superinfection.
(2) Ọ nwere ụfọdụ nephrotoxicity.
(3) Mgbu mgbu na-agafe agafe nwere ike ime.
Mkpachapụ anya
(1) Dị njikere iji.
(2) Ekwesịrị ịhazi dose ahụ maka ụmụ anụmanụ nwere ụkọ akụrụngwa.
(3) Ndị nwere mmetụta nke ukwuu maka ọgwụ nje beta-lactam kwesịrị izere ịkpọtụrụ ngwaahịa a.
Mmekọrịta ọgwụ
Ọ nwere mmetụta synergistic mgbe ejiri ya na penicillin na aminoglycosides.
Oge mwepụ
4 ụbọchị maka ezi.
Njirimara
Ngwaahịa a na-acha ọcha ka ntụ ntụ odo na-acha ntụ ntụ ma ọ bụ lumps rụrụ arụ
Nchekwa
Ndo, kpuchie ikuku, ma chekwaa n'ebe dị mma.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
